Koehler eClinical, a specialty contract research organization, is excited to announce that due to growth and high customer loyalty, its expansion continues with the opening of new offices in Mannheim, Germany effective January 2020.
The Mannheim office will support the growth in our core business area biostatistics and programming, with an initial team of 5 Biostatisticians and Statistical Programmers that come with a track record of having worked successfully together for years at Prometris GmbH.
“We are excited to expand our biometrics division with this very experienced group from Prometris, who wished to continue working together as a team, and are also particularly grateful to the Prometris management for their dedicated support in making this possible.” said Dr. Antal K. Hajos, CEO of Koehler eClinical. “We are pleased that the former Prometris Biostatistics Department has found a good new home together at Koehler eClinical.”, says Steffen Koenig, CRO of Prometris and IST GmbH.
The opening of the new Mannheim office, the 4thlocation of Koehler eClinical offices after Berlin, Constance and the headquarter office in Freiburg, follows the management handover in July last year to Michael Pfitzenmaier and Dr. Antal K. Hajos as new CEOs by Dr. Manfred Köhler, who remains as sole owner and Chair of the Board.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.